257 related articles for article (PubMed ID: 20921210)
1. Intratumoral mediated immunosuppression is prognostic in genetically engineered murine models of glioma and correlates to immunotherapeutic responses.
Kong LY; Wu AS; Doucette T; Wei J; Priebe W; Fuller GN; Qiao W; Sawaya R; Rao G; Heimberger AB
Clin Cancer Res; 2010 Dec; 16(23):5722-33. PubMed ID: 20921210
[TBL] [Abstract][Full Text] [Related]
2. miR-124 inhibits STAT3 signaling to enhance T cell-mediated immune clearance of glioma.
Wei J; Wang F; Kong LY; Xu S; Doucette T; Ferguson SD; Yang Y; McEnery K; Jethwa K; Gjyshi O; Qiao W; Levine NB; Lang FF; Rao G; Fuller GN; Calin GA; Heimberger AB
Cancer Res; 2013 Jul; 73(13):3913-26. PubMed ID: 23636127
[TBL] [Abstract][Full Text] [Related]
3. Effective immuno-targeting of the IDH1 mutation R132H in a murine model of intracranial glioma.
Pellegatta S; Valletta L; Corbetta C; Patanè M; Zucca I; Riccardi Sirtori F; Bruzzone MG; Fogliatto G; Isacchi A; Pollo B; Finocchiaro G
Acta Neuropathol Commun; 2015 Jan; 3():4. PubMed ID: 25849072
[TBL] [Abstract][Full Text] [Related]
4. Immune modulatory nanoparticle therapeutics for intracerebral glioma.
Yaghi NK; Wei J; Hashimoto Y; Kong LY; Gabrusiewicz K; Nduom EK; Ling X; Huang N; Zhou S; Kerrigan BC; Levine JM; Fajt VR; Levine G; Porter BF; Marcusson EG; Tachikawa K; Chivukula P; Webb DC; Payne JE; Heimberger AB
Neuro Oncol; 2017 Mar; 19(3):372-382. PubMed ID: 27765835
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal stem cells display tumor-specific tropism in an RCAS/Ntv-a glioma model.
Doucette T; Rao G; Yang Y; Gumin J; Shinojima N; Bekele BN; Qiao W; Zhang W; Lang FF
Neoplasia; 2011 Aug; 13(8):716-25. PubMed ID: 21847363
[TBL] [Abstract][Full Text] [Related]
6. Immune Microenvironment Landscape in CNS Tumors and Role in Responses to Immunotherapy.
Najem H; Khasraw M; Heimberger AB
Cells; 2021 Aug; 10(8):. PubMed ID: 34440802
[TBL] [Abstract][Full Text] [Related]
7. Genetically engineered rat gliomas: PDGF-driven tumor initiation and progression in tv-a transgenic rats recreate key features of human brain cancer.
Connolly NP; Stokum JA; Schneider CS; Ozawa T; Xu S; Galisteo R; Castellani RJ; Kim AJ; Simard JM; Winkles JA; Holland EC; Woodworth GF
PLoS One; 2017; 12(3):e0174557. PubMed ID: 28358926
[TBL] [Abstract][Full Text] [Related]
8. Sox10 has a broad expression pattern in gliomas and enhances platelet-derived growth factor-B--induced gliomagenesis.
Ferletta M; Uhrbom L; Olofsson T; Pontén F; Westermark B
Mol Cancer Res; 2007 Sep; 5(9):891-7. PubMed ID: 17855658
[TBL] [Abstract][Full Text] [Related]
9. Glioma escape signature and clonal development under immune pressure.
Maire CL; Mohme M; Bockmayr M; Fita KD; Riecken K; Börnigen D; Alawi M; Failla A; Kolbe K; Zapf S; Holz M; Neumann K; Dührsen L; Lange T; Fehse B; Westphal M; Lamszus K
J Clin Invest; 2020 Oct; 130(10):5257-5271. PubMed ID: 32603315
[TBL] [Abstract][Full Text] [Related]
10. Effective Treatment of Established GL261 Murine Gliomas through Picornavirus Vaccination-Enhanced Tumor Antigen-Specific CD8+ T Cell Responses.
Renner DN; Jin F; Litterman AJ; Balgeman AJ; Hanson LM; Gamez JD; Chae M; Carlson BL; Sarkaria JN; Parney IF; Ohlfest JR; Pirko I; Pavelko KD; Johnson AJ
PLoS One; 2015; 10(5):e0125565. PubMed ID: 25933216
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance imaging determination of tumor grade and early response to temozolomide in a genetically engineered mouse model of glioma.
McConville P; Hambardzumyan D; Moody JB; Leopold WR; Kreger AR; Woolliscroft MJ; Rehemtulla A; Ross BD; Holland EC
Clin Cancer Res; 2007 May; 13(10):2897-904. PubMed ID: 17504989
[TBL] [Abstract][Full Text] [Related]
12. Radiation with STAT3 Blockade Triggers Dendritic Cell-T cell Interactions in the Glioma Microenvironment and Therapeutic Efficacy.
Ott M; Kassab C; Marisetty A; Hashimoto Y; Wei J; Zamler D; Leu JS; Tomaszowski KH; Sabbagh A; Fang D; Gupta P; Priebe W; Zielinski RJ; Burks JK; Long JP; Kong LY; Fuller GN; DeGroot J; Sulman EP; Heimberger AB
Clin Cancer Res; 2020 Sep; 26(18):4983-4994. PubMed ID: 32605912
[TBL] [Abstract][Full Text] [Related]
13. Effect of miR-142-3p on the M2 macrophage and therapeutic efficacy against murine glioblastoma.
Xu S; Wei J; Wang F; Kong LY; Ling XY; Nduom E; Gabrusiewicz K; Doucette T; Yang Y; Yaghi NK; Fajt V; Levine JM; Qiao W; Li XG; Lang FF; Rao G; Fuller GN; Calin GA; Heimberger AB
J Natl Cancer Inst; 2014 Aug; 106(8):. PubMed ID: 24974128
[TBL] [Abstract][Full Text] [Related]
14. CpG-1826 immunotherapy potentiates chemotherapeutic and anti-tumor immune responses to metronomic cyclophosphamide in a preclinical glioma model.
Jordan M; Waxman DJ
Cancer Lett; 2016 Apr; 373(1):88-96. PubMed ID: 26655275
[TBL] [Abstract][Full Text] [Related]
15. TLR ligands in the local treatment of established intracerebral murine gliomas.
Grauer OM; Molling JW; Bennink E; Toonen LW; Sutmuller RP; Nierkens S; Adema GJ
J Immunol; 2008 Nov; 181(10):6720-9. PubMed ID: 18981089
[TBL] [Abstract][Full Text] [Related]
16. FasL gene knock-down therapy enhances the antiglioma immune response.
Jansen T; Tyler B; Mankowski JL; Recinos VR; Pradilla G; Legnani F; Laterra J; Olivi A
Neuro Oncol; 2010 May; 12(5):482-9. PubMed ID: 20406899
[TBL] [Abstract][Full Text] [Related]
17. High-grade glioma associated immunosuppression does not prevent immune responses induced by therapeutic vaccines in combination with T
Löhr M; Freitag B; Technau A; Krauss J; Monoranu CM; Rachor J; Lutz MB; Hagemann C; Kessler AF; Linsenmann T; Wölfl M; Ernestus RI; Engelhardt S; Gelbrich G; Schlegel PG; Eyrich M
Cancer Immunol Immunother; 2018 Oct; 67(10):1545-1558. PubMed ID: 30054667
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic Efficacy of Immune Stimulatory Thymidine Kinase and fms-like Tyrosine Kinase 3 Ligand (TK/Flt3L) Gene Therapy in a Mouse Model of High-Grade Brainstem Glioma.
Mendez F; Kadiyala P; Nunez FJ; Carney S; Nunez FM; Gauss JC; Ravindran R; Pawar S; Edwards M; Garcia-Fabiani MB; Haase S; Lowenstein PR; Castro MG
Clin Cancer Res; 2020 Aug; 26(15):4080-4092. PubMed ID: 32332014
[TBL] [Abstract][Full Text] [Related]
19. Dynamics of central and peripheral immunomodulation in a murine glioma model.
Kennedy BC; Maier LM; D'Amico R; Mandigo CE; Fontana EJ; Waziri A; Assanah MC; Canoll P; Anderson RC; Anderson DE; Bruce JN
BMC Immunol; 2009 Feb; 10():11. PubMed ID: 19226468
[TBL] [Abstract][Full Text] [Related]
20. Genetically Engineered T-Cells for Malignant Glioma: Overcoming the Barriers to Effective Immunotherapy.
Chuntova P; Downey KM; Hegde B; Almeida ND; Okada H
Front Immunol; 2018; 9():3062. PubMed ID: 30740109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
